Dec. 27, 2022

A Brief Chat with Rob Etherington, President & CEO of Clene, Inc.

A Brief Chat with Rob Etherington, President & CEO of Clene, Inc.
Spotify podcast player badge
Apple Podcasts podcast player badge
Pandora podcast player badge
RSS Feed podcast player badge
Spotify podcast player icon Apple Podcasts podcast player icon Pandora podcast player icon RSS Feed podcast player icon

In this 15-minute chat, Rob Etherington, President & CEO of Clene, Inc. (NASDAQ: CLNN) discusses the potential for nanosuspensions to improve cellular energy production and treat neurodegenerative diseases, along with Clene’s future directions.